About Us
Alexander Vinitsky, Ph.D.
Principal and Co-founder
E-mail: avinitsky@arvysproteins.com
Phone: 203.304.2495 ext. 2#
Alexander Vinitsky's experience in protein biochemistry and enzymology spans over 15 years in academia and pharmaceutical industry. Prior to co-founding ARVYS Proteins, he held a faculty position at the Mount Sinai Medical School and senior staff positions at Bristol-Myers Squibb and Palatin Technologies. Among his achievements are contributions to the improved understanding of the mechanism and functions of regulated protein degradation and to the characterization of proteins involved in Alzheimer's disease. As a part of Dr. Vinitsky's effort in the pharmaceutical industry, he directed purification and characterization of protein targets for potential therapeutics and developed numerous assays for screening of compounds against those drug targets. Dr. Vinitsky is an expert in biophysical/biochemical characterization of proteins and peptides and in assay development. He holds a B.A. in Biology and a Ph.D. in Biochemistry from New York University. His post-doctoral work was carried out at the Mount Sinai School of Medicine.
Yelena Sheptovitsky, Ph.D., M.B.A
Principal and Co-founder
E-mail: ysheptovitsky@arvysproteins.com
Phone: 203.304.2495 ext. 3#
Yelena Sheptovitsky has over 13 years of research and development experience. She held senior staff positions at International Bioimmune Systems, Inc. and Acorda Therapeutics, Inc. As a protein biochemistry team leader, she contributed to the development of protein-based therapeutics including enzymes, growth factors and antibodies of various isotypes. Throughout her career Dr. Sheptovitsky worked with various integral membrane proteins that function as tumor antigens, cell adhesion molecules and electron-transfer systems. Her areas of expertise are purification, characterization, stabilization and formulation of proteins, antigen identification. Dr. Sheptovitsky has a M.S. degree in Chemistry from Moscow State University, a Ph.D. in Biochemistry from Yale University and conducted her post-doctoral work at Memorial Sloan-Kettering Cancer Center. In addition to her scientific background Dr. Sheptovitsky holds a M.B.A. degree from the University of Connecticut.
Nikos Panayotatos, Ph.D.
Consulting Director
E-mail: npanayotatos@arvysproteins.com
Web Site: www.biotechnology-expert.com
Phone: 203.304.2495 ext. 4#
Nikos Panayotatos has over 25 years of academic, industrial and consulting experience in R&D of biologics. He has held senior positions at Biogen, Michigan Biotechnology Institute and Regeneron Pharmaceuticals. He has planned and directed the development of many recombinant proteins as therapeutics, such as interferon, cytokines and neurotrophic factors. He has invented gene expression systems, protein production technology, rationally designed proteins and novel methods for delivering small molecules for therapeutic use. His work is described in over 40 major publications, 17 US patents and over 50 patents worldwide. Dr. Panayotatos has received degrees from the University of Athens (B.Sc.), Ohio University (M.Sc.) and Loyola University of Chicago (Ph.D.) and conducted post-doctoral work at the University of Wisconsin. He speaks English, Greek and French.
